Reply  by Thomas, James D et al.
points. In fact, inertial drop is unaffected by the distance between
measurement points when these are sufficiently outside the mitral
jet core. In contrast, the convective force plays a role only when the
second point is within the jet core; otherwise, its contribution is
negligible.
The graph of pressure drop reported in Figure 2 of Firstenberg
et al. (1) study and computed between points 5 cm apart can be
misleading and of difficult interpretation because it is not linked to
a space-time map of pressure. A relevant positive contribution of
convection is shown there, which is always between 0.5 and
1 mm Hg during the entire filling period. This means that the
velocity in the ventricle, at a distance of 3 cm from the mitral plane,
must be always .25 cm/s, even in the diastasic period, which for
a normal heart rate and normal flow propagation velocity is not a
common finding. In addition, it is also difficult to understand how
the total pressure may remain positive during the deceleration
phase of the E-wave. In fact, because the inertial contribution is
the flow acceleration, during deceleration the pressure increases
along the direction of flow; thus, a negative atrium-ventricular
pressure difference can be predictable.
From the space-temporal maps, we calculated the pressure
difference among three pairs of points at different distances, and
the respective results are plotted in Figure 1. As we can see, the
convective term disappears when the points are separated by 5 cm
(2 cm inside the atrium to 3 cm in the ventricle), a distance similar
to the example by Firstenberg et al. (1). In our example, the two
points are outside the jet core, and the pressure drop is zero at the
maximum of mitral velocity. Figure 1 shows little changes when
the two points are closer (1 cm in the atrium and 2 cm in the
ventricle). In contrast, an important convective effect appears only
when the second point is placed inside the jet (1 cm into the
ventricle). In this case, the pressure presents a comparable influ-
ence of both terms. However, even in this case, pressure at the
E-wave still presents an inversion of sign at the end of the
deceleration when inertia is negative and velocity (convection) goes
to zero.
In conclusion, we underline how convective and inertial terms of
pressure are dependent from the relative position of measurement
points. Space allocation of convective and inertial forces by the
analysis of the atrioventricular velocity field allows a better inter-
pretation of pressure map in hemodynamic terms.
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REPLY
We appreciate the comments of Tonti et al. regarding our recent
publication (1). We agree that transmitral flow is a very complex
three-dimensional process that can be approached only as an
approximation when the Euler equation is applied to color
M-mode images. Nevertheless, previous studies (2) using contrast
agents have demonstrated that most of the streamlines of flow
follow a unidirectional vector along the long axial dimension of the
left ventricle (LV). The validity of this concept is further supported
by the accuracy of our results. In fact, we demonstrated that this
approach could quite accurately predict the total pressure drop
across the normal mitral valve, an impossible task with the
simplified Bernoulli equation. Tonti et al. correctly point out that
display of pressure differences at just two locations misses the
subtlety of the spatiotemporal pressure distribution within the LV
inflow tract; our methodology, in fact, provides the full spatiotem-
poral map from which we extracted pressures at locations corre-
sponding to our multisensor catheter. Tonti et al. state that the
convective term should completely cancel out at a 5-cm sensor
separation, but this assumes complete pressure recovery across the
valve, which may not occur owing to turbulence in the inflow jet
and vortices that form at the mitral tips. Indeed, if there were
complete pressure recovery, there would be no net pressure drop
across even stenotic valves.
The noninvasive calculation of true pressure drop across the
normal mitral valve is only one application of quantitative analysis
of the color M-mode Doppler image. Even more remarkably, this
approach has been shown to be able to quantify the very small (1–4
mm Hg) pressure gradients between the base and apex of the LV
that are a manifestation of diastolic suction. This has been
validated in a canine model (3), and it was recently used to detect
the 1–2-mm Hg increase in diastolic suction that occurs in
submaximal exercise (4). Such gradients have been shown to
decrease in ischemia (5) and increase with revascularization (6).
Thus, digital image processing of color M-mode data may yield
new noninvasive quantification of diastolic function that should be
widely applicable in the clinical setting.
Although the measurement of the very small pressure gradients
is difficult even by (perhaps especially by!) micromanometer
catheters, we believe that our data are as accurate as can currently
be obtained in patients, and we stand by our analysis as presented.
We hope that studies such as ours (1,3,4,6) and by Tonti et al. (7)
will stimulate further interest in quantitative color Doppler anal-
ysis.
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Paclitaxel-Coated Stent:
Is There a Light at the End of the Tunnel?
We read with great interest the study by Drachman et al.(1). Their
study determines long-term effects of stent-based paclitaxel deliv-
ery and its influence on neointimal thickening in a rabbit injury
model.
Their report highlights the importance of stents with drug
delivery capabilities and therefore signals the beginning of the era
of “smart” stents. An important question unanswered in their study
is the gender bias in paclitaxel therapy. It is well established that
the chemotherapeutic effect of paclitaxel is mediated through the
plasma membrane estrogen receptors (2). It is also widely accepted
that this is particularly effective in breast and ovarian neoplasms
(3–5).
In contrast, the estrogen receptors in the human cells, including
arterial smooth muscle cells (SMC), are probably less developed in
the male cell system. Therefore, it will be extremely interesting to
investigate the effect of paclitaxel-coated stents on myointimal
hyperplasia in male and female animals.
Another issue of this antiproliferative approach for restenosis is
the nonselective nature of this modality, which also includes
suppression of endothelial cell growth. Although the Drachman et
al. (1) study along with others demonstrates complete endotheli-
alization of the coated stents at follow-up, histology is not always
an absolute indicator of the endothelialization process. Many
believe there is the phenomenon of pseudo-endothelialization.
Synthetic or proliferative SMC that line the surface of the vessel
after injury may perform many, but not all, functions of endothelial
cells. Therefore, functional studies are necessary to address the
issue of true endothelialization and, subsequently, late thrombosis.
Finally, the issue of modulation of collagen production by SMC
needs to be addressed. The arrest of SMC migration and prolif-
eration will not be enough to reverse the process of restenosis. It
might be that paclitaxel therapy of the vessel wall also abolishes
collagen production. Importantly, further in vitro and in vivo
studies will help to understand antirestenotic properties of this
compound.
Thus, additional experimental studies that will address all these
issues might indeed allow us to see the beginning of the end of a
long and difficult journey of restenosis prevention.
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REPLY
We very much appreciate the comments of Kipshidze et al.
regarding our report on long-term reduction of experimental
restenosis using a paclitaxel-releasing stent (1). Their insights
underscore the challenges we all face in translating “bench-top”
triumphs to techniques that benefit our patients.
It is interesting to consider the role played by the estrogen
receptor in smooth muscle cell migration and proliferation (2), and
it will be important to determine whether paclitaxel’s antirestenotic
effects are, at least in part, effected through this receptor system. It
is worth noting, however, that paclitaxel’s effects are myriad, and
that attributing all to plasma membrane estrogen receptors may
not be accurate. Such mechanistic insight may extend our under-
standing of clinical restenosis.
We reiterate concerns that experimental models of endothelial
cell function are incomplete and may not always mirror responses
in humans. Following experimental arterial injury, the endothe-
lium plays an important role in guiding the healing process,
modulating neointimal proliferation, controlling extracellular ma-
trix deposition, regulating vasomotor tone, and protecting against
luminal thrombus deposition. Although present laboratory meth-
ods allow us to examine the histologic impact of arterial injury on
endothelial viability, specific aspects of endothelial cell function are
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